Patent details

EP3204376 Title: INDOLINONE COMPOUNDS AND USES THEREOF

Basic Information

Publication number:
EP3204376
PCT Application Number:
US2015054533
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157842378
PCT Publication Number:
WO2016057698
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INDOLINONE COMPOUNDS AND USES THEREOF
French Title of Invention:
COMPOSÉS D'INDOLINONE ET LEURS UTILISATIONS
German Title of Invention:
INDOLINVERBINDUNGEN UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
07/10/2015
Grant date:
19/04/2023
EP Publication Date:
16/08/2017
PCT Publication Date:
14/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/04/2023
EP B1 Publication Date:
19/04/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/10/2023
Expiration date:
07/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/04/2023
 
 

Name:
Oncternal Therapeutics, Inc.
Address:
3525 Del Mar Heights Road, 821, San Diego CA 92130, United States (US)

Inventor

Name:
VERNIER, Jean-Michel
Address:
United States (US)

Priority

Priority Number:
201462062086 P
Priority Date:
09/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07D 401/10; A61K 31/404; A61K 31/4155; A61K 31/4439; C07D 403/10; C07D 209/34; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202316
Publication date:
19/04/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages